American College of Allergy, Asthma and Immunology (ACAAI)

During COVID-19 Pandemic, Normal Allergy and Asthma Medications Should Be Continued

During COVID-19 Pandemic, Normal Allergy and Asthma Medications Should Be Continued

Newswise — ARLINGTON HEIGHTS, Ill. (March 26, 2020) – In response to numerous inquiries from the public, the American College of Allergy, Asthma & Immunology (ACAAI) is providing guidance on the continued use of corticosteroids for patients with allergies and asthma during the COVID-19 pandemic.

As spring allergy season sets in, allergy and asthma sufferers may be concerned that continuing their normal use of inhaled and intranasal corticosteroids may not be advisable during the pandemic. However, it is more important than ever for these patients to keep their symptoms well controlled.

The ACAAI has provided the following statement:

With the COVID-19 pandemic coinciding with the Spring allergy season, you may be concerned about using your intranasal corticosteroids for nasal allergies and your inhaled corticosteroids for your asthma. There is no data to suggest that continuing these allergy and asthma medications will have any effect on increasing your risk of getting the COVID-19 infection, or if you get the infection, lead to a worse outcome. It is important to control your allergy and asthma symptoms as they could potentially lead to misdiagnosis of COVID-19 if there were an overlap of some symptoms. 

If you have questions about your allergy and asthma medications, please contact your allergist or asthma specialist.

About ACAAI

The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

 

 




Filters close

Showing results

110 of 2503
Newswise: Ozone Disinfection Could Allow Safe Reuse of Personal Protective Equipment (PPE)
Released: 8-Jul-2020 8:05 PM EDT
Ozone Disinfection Could Allow Safe Reuse of Personal Protective Equipment (PPE)
Georgia Institute of Technology

A new study shows that ozone gas, a highly reactive chemical composed of three oxygen atoms, could provide a safe means for disinfecting certain types of personal protective equipment that are in high demand for shielding health care personnel from Covid-19.

Released: 8-Jul-2020 6:35 PM EDT
A data visualization platform that tracks countries' progress on meaningful access to information
University of Washington

The Technology & Social Change Group at the University of Washington Information School has released the Development and Access to Information Dashboards, a data visualization platform that tracks the progress of countries and regions on key indicators related to three dimensions of meaningful access to information: Connectivity, Freedom and Gender Equity.

Newswise: Williams-Brent-cropped.jpg
Released: 8-Jul-2020 5:15 PM EDT
Signatory to letter to WHO focused on understanding virus transmission by aerosols
Washington University in St. Louis

On Monday, more than 230 scientists from around the world declared “It’s time to address airborne transmission of COVID-19.”In a letter signed by Washington University in St. Louis faculty and published in the journal Clinical Infectious Diseases, directed toward “Most public health organizations, including the World Health Organization,” the scientists urged that public health organizations need to make recommendations beyond hand washing and mask-wearing.

Released: 8-Jul-2020 3:40 PM EDT
Special unit will treat nursing home patients with COVID-19 in Jefferson County
University of Alabama at Birmingham

UAB will establish a special 25-bed unit to treat patients from nursing home facilities who have COVID-19. The unit will isolate nursing home residents who test positive and are asymptomatic or mildly symptomatic, while providing the appropriate level of skilled nursing care that those patients require.

Released: 8-Jul-2020 3:40 PM EDT
New Study Finds COVID-19 Impact on Community Radiology Practices
Harvey L. Neiman Health Policy Institute

The COVID-19 pandemic has quickly spread across all 50 United States. Associated recommendations that healthcare facilities defer non-urgent visits, tests, and procedures led many imaging facilities to temporarily curtail most of their non-urgent services. This new Neiman Institute study characterizes the recent declines in non-invasive imaging volumes at community practices.

Released: 8-Jul-2020 2:05 PM EDT
Researchers propose novel approach to limit organ damage, improve outcomes for patients with severe COVID-19
Beth Israel Deaconess Medical Center

In a paper published in Cancer and Metastasis Reviews, a team of researchers from Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital propose that controlling the local and systemic inflammatory response in COVID-19 may be as important as anti-viral and other therapies.

Released: 8-Jul-2020 2:05 PM EDT
Mount Sinai Researcher Receives NIH Award to Study Immune Responses of Patients With Inflammatory Skin Diseases in the Setting of COVID-19 Infection
Mount Sinai Health System

The study will aim to understand whether systemic medications and biologics, such as dupilumab—a monoclonal antibody that binds to an inflammatory molecule, IL-4 receptor alfa, and inhibits the inflammatory response that leads to rashes and itching from atopic dermatitis/eczema—may have a positive or negative impact on COVID-19 responses in patients who have the disease.

Newswise: 236796_web.jpg
Released: 8-Jul-2020 1:10 PM EDT
Researchers create air filter that can kill the coronavirus
University of Houston

Researchers from the University of Houston, in collaboration with others, have designed a "catch and kill" air filter that can trap the virus responsible for COVID-19, killing it instantly.

Newswise:Video Embedded pandemic-could-make-drug-resistance-epidemic-worse
VIDEO
Released: 8-Jul-2020 11:50 AM EDT
Pandemic could make drug resistance epidemic worse
University of Georgia

Researchers fear that widespread use of antibiotics during the coronavirus pandemic will add fuel to the fire, making more common infections that were once treatable possibly life threatening.


Showing results

110 of 2503

close
1.12376